pyrazines has been researched along with Crow-Fukase Syndrome in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (6.67) | 29.6817 |
| 2010's | 14 (93.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, L; Liu, T; Liu, ZG; Niu, T; Yang, JR; Yang, YM; Zeng, K | 1 |
| Hagihara, M; Hattori, Y; Ishigatsubo, Y; Ishii, Y; Ishiyama, Y; Tomita, N; Yamamoto, E; Yamazaki, E | 1 |
| Creamer, A; Gaastra, B; Odogwu, S; Whitelaw, B | 1 |
| Alonso Vence, N; Bello Lopez, JL; Bendaña Lopez, A; Diaz Arias, J; Fraga Rodriguez, M; Sobas, MA | 1 |
| Gu, B; Liu, Y; Qiu, H; Ruan, C; Shi, X; Sun, A; Tang, X; Wu, D; Xue, S; Zhou, H | 1 |
| Bayik, M; Cetiner, M; Kaygusuz, I; Kocakaya, O; Tezcan, H; Uzay, A | 1 |
| Fukuhara, N; Harigae, H; Ichinohasama, R; Ishizawa, K; Ohba, R; Ohguchi, H; Okitsu, Y; Onishi, Y; Yamamoto, J | 1 |
| Gao, J; Wang, X; Xiao, C; Xing, X; Xiong, C; Ye, S | 1 |
| Albrecht, P; Braun, SA; Hanneken, S; Methner, A | 1 |
| Kuwabara, S | 1 |
| Li, LH; Tang, XW; Zhang, R | 1 |
| Dispenzieri, A; Kohut, IE; Warsame, R | 1 |
| Cao, XX; Duan, MH; Kang, WY; Li, J; Zhang, W; Zhou, DB | 1 |
| Li, J; Liu, T; Niu, T; Wei, Q; Yang, JR; Yang, YM; Zeng, K | 1 |
| Li, J; Zhou, DB | 1 |
4 review(s) available for pyrazines and Crow-Fukase Syndrome
| Article | Year |
|---|---|
[Treatment for POEMS syndrome with subcutaneous administration of bortezomib followed by autologous peripheral blood stem cell transplantation: a case report and literatures review].
Topics: Boronic Acids; Bortezomib; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Pyrazines; Transplantation, Autologous | 2013 |
[New treatment strategy for Crow-Fukase (POEMS) syndrome].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Combined Modality Therapy; Demyelinating Diseases; Humans; Lenalidomide; Melphalan; Peripheral Blood Stem Cell Transplantation; POEMS Syndrome; Pyrazines; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2010 |
Effective induction therapy with subcutaneous administration of bortezomib for newly diagnosed POEMS syndrome: a case report and a review of the literature.
Topics: Administration, Oral; Boronic Acids; Bortezomib; Dexamethasone; Humans; Injections, Subcutaneous; Male; Middle Aged; Neoadjuvant Therapy; POEMS Syndrome; Pyrazines; Remission Induction | 2013 |
New advances in the diagnosis and treatment of POEMS syndrome.
Topics: Antibodies, Monoclonal, Humanized; Bevacizumab; Boronic Acids; Bortezomib; Castleman Disease; Chromosome Aberrations; Combined Modality Therapy; Dexamethasone; Disease Management; Drug Therapy, Combination; Genes, Immunoglobulin; Humans; Hypertension, Pulmonary; Lenalidomide; Melphalan; Osteosclerosis; Peripheral Blood Stem Cell Transplantation; Plasma Cells; POEMS Syndrome; Prognosis; Pyrazines; Severity of Illness Index; Symptom Assessment; Thalidomide; Transplantation, Autologous; Vascular Endothelial Growth Factor A | 2013 |
11 other study(ies) available for pyrazines and Crow-Fukase Syndrome
| Article | Year |
|---|---|
Successful treatment of POEMS syndrome with bortezomib and dexamethasone, combined with radiotherapy, and followed by autologous stem cell transplantation.
Topics: Adult; Boronic Acids; Bortezomib; Dexamethasone; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; POEMS Syndrome; Positron-Emission Tomography; Pyrazines; Radiotherapy; Tomography Scanners, X-Ray Computed; Transplantation, Autologous; Treatment Outcome | 2013 |
POEMS syndrome: a challenging diagnosis of a rare disease.
Topics: Adult; Antineoplastic Agents; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Male; POEMS Syndrome; Pyrazines; Rare Diseases | 2014 |
Efficacy of bortezomib in refractory form of multicentric Castleman disease associated to poems syndrome (MCD-POEMS variant).
Topics: Boronic Acids; Bortezomib; Castleman Disease; Humans; Male; Middle Aged; POEMS Syndrome; Protease Inhibitors; Pyrazines; Treatment Outcome | 2010 |
Successful bortezomib-based treatment in POEMS syndrome.
Topics: Adult; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cyclophosphamide; Cytarabine; Depression, Chemical; Dexamethasone; Doxorubicin; Drug Therapy, Combination; Humans; Male; Melphalan; Plasma Cells; POEMS Syndrome; Prednisone; Protease Inhibitors; Pyrazines; Remission Induction; Vascular Endothelial Growth Factor A; Vincristine | 2009 |
Bortezomib: a new therapeutic option for POEMS syndrome.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Glycoproteins; Humans; Male; POEMS Syndrome; Pyrazines; Remission Induction | 2010 |
Successful treatment with bortezomib and thalidomide for POEMS syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Female; Humans; Middle Aged; POEMS Syndrome; Pyrazines; Radionuclide Imaging; Remission Induction; Thalidomide; Treatment Outcome | 2011 |
Successful treatment with bortezomib and thalidomide for POEMS syndrome associated with multicentric mixed-type Castleman's disease.
Topics: Adult; Angiogenesis Inhibitors; Boronic Acids; Bortezomib; Castleman Disease; Drug Therapy, Combination; Humans; Male; POEMS Syndrome; Pyrazines; Thalidomide; Vascular Endothelial Growth Factor A | 2011 |
[POEMS syndrome. An interdisciplinary clinical challenge].
Topics: Antineoplastic Agents; Antineoplastic Agents, Hormonal; Boronic Acids; Bortezomib; Cooperative Behavior; Dexamethasone; Drug Therapy, Combination; Humans; Immunoglobulin lambda-Chains; Interdisciplinary Communication; Male; Middle Aged; Paraproteinemias; POEMS Syndrome; Pyrazines; Vascular Endothelial Growth Factor A | 2011 |
[Autologous hematopoietic stem cell transplantation following bortezomib-based chemotherapy for one case with POEMS syndrome].
Topics: Adult; Boronic Acids; Bortezomib; Combined Modality Therapy; Female; Hematopoietic Stem Cell Transplantation; Humans; POEMS Syndrome; Pyrazines | 2011 |
Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Humans; Male; Paraneoplastic Syndromes; POEMS Syndrome; Pyrazines; Recurrence | 2012 |
Bortezomib and dexamethasone as first-line therapy for a patient with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes syndrome complicated by renal failure.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Boronic Acids; Bortezomib; Dexamethasone; Drug Therapy, Combination; Humans; Induction Chemotherapy; Male; Middle Aged; POEMS Syndrome; Pyrazines; Renal Insufficiency; Treatment Outcome | 2012 |